Vertex Pharmaceuticals (VRTX) Profit After Tax Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 59.59% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -10.08% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -129.68% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1,228.66% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.59% |
| Dec 31, 2025 | 30.46% |
| Sep 30, 2025 | 3.59% |
| Jun 30, 2025 | 128.74% |
| Mar 31, 2025 | -41.22% |
| Dec 31, 2024 | -5.76% |
| Sep 30, 2024 | 0.98% |
| Jun 30, 2024 | -492.44% |
| Mar 31, 2024 | 57.13% |
| Dec 31, 2023 | 18.31% |
| Sep 30, 2023 | 11.26% |
| Jun 30, 2023 | 12.98% |
| Mar 31, 2023 | -8.17% |
| Dec 31, 2022 | 6.34% |
| Sep 30, 2022 | 9.23% |
| Jun 30, 2022 | 1,109.70% |
| Mar 31, 2022 | 16.69% |
| Dec 31, 2021 | 27.46% |
| Sep 30, 2021 | 27.64% |
| Jun 30, 2021 | -92.00% |
| Mar 31, 2021 | 8.35% |
| Dec 31, 2020 | 3.59% |
| Sep 30, 2020 | 1,060.39% |
| Jun 30, 2020 | 213.08% |
| Mar 31, 2020 | 124.38% |
| Dec 31, 2019 | -62.38% |
| Sep 30, 2019 | -55.32% |
| Jun 30, 2019 | 28.97% |
| Mar 31, 2019 | 27.76% |
| Dec 31, 2018 | 1,439.99% |
| Sep 30, 2018 | 144.20% |
| Jun 30, 2018 | 1,052.26% |
| Mar 31, 2018 | -15.74% |
| Dec 31, 2017 | 262.71% |
| Sep 30, 2017 | -649.90% |
| Jun 30, 2017 | 149.78% |
| Mar 31, 2017 | 699.43% |
| Dec 31, 2016 | 137.18% |
| Sep 30, 2016 | 58.60% |
| Jun 30, 2016 | 83.64% |